professionaladviser_logo

FOR SUSTAINABLE, PROFITABLE, CLIENT-FOCUSED ADVISER FIRMS

pin Sign in Join
pin
    • My account
    • Sign out
  • You are currently accessing Professional Adviser via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
logo
  • logo

    Search Professional Adviser

  • News
  • More

    Choose from below

    • Features
    • Opinion
    • News Analysis
    • People Moves
    • Market Movers
    • Interviews
    • Professional Adviser TV
  • Your Business
    • Recruitment
    • Platforms
    • MPS
    • Education
    • Technology
    • Paraplanning
    • Diversity
    • Succession planning
  • Your Profession
    • Pensions
    • Investment
    • Regulation
    • ESG
    • Protection
    • Estate planning
    • Tax planning
    • Retirement
  • Consumer Duty
  • Events
  • About

    Authors

    • Jen Frost
    • Jenna Brown
    • Sahar Nazir
    • Isabel Baxter

    Featured Content

    • Cost of Living
    • Partner Insight
    • InvestmentIQ
    • PA360 Watchlist

    Sister publications

    • BusinessGreen
    • COVER
    • Investment Week
    • Professional Pensions

    Incisive Media

    • Our company
    • Careers
  • Searchlogo

    Search Professional Adviser

    x
Join Sign in
 
    • My account
    • Sign out
  • You are currently accessing Professional Adviser via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0) 1858 438800

    Email: [email protected]

    • Sign in
    • Sign in

Protection

PMI

NICE rejects three expensive leukaemia drugs

The National Institute for Health Clinical Excellence (Nice) has provisionally rejected three commonly used leukaemia drugs for being too expensive compared to the benefit they bring.

clock 05 May 2011 •

Protection

Blog: Is this as good as it gets for protection?

Is the public really unaware of protection products and their benefits?

clock 05 May 2011 •

Individual Protection

Cuna agrees to sell LV='s term assurance product

Cuna Mutual Group has announced a deal to distribute LV='s term life assurance to its network of building societies.

clock 05 May 2011 •

Protection

Protect expands its reach with protection industry speakers

Protect has confirmed representatives from the Protection Review, Income Protection Task Force and Defaqto will be speaking at its May meeting.

clock 04 May 2011 •

PMI

Europ Assistance agrees tie-up with Premier OH

Europ Assistance has partnered with Premier Occupational Healthcare as part of its expansion into healthcare and home and family assistance.

clock 04 May 2011 •

Individual Protection

Pre-existing conditions specialist adviser launches

An advice service focussed on helping people with pre-existing medical conditions obtain life cover has been launched into the UK protection market.

clock 04 May 2011 •

Long Term Care

Planet Insurance - LTC and the private sector

Long-term care (LTC) has always been in the ‘too difficult' box, as successive government reviews and think tanks have advocated varying roles for the private insurance sector.

clock 03 May 2011 •

Your profession

Aegon says FSA must forget product price capping

Capping prices or requiring advisers to benchmark recommendations against lower-charged substitutable products could have unintended consequences for consumers, insurer Aegon UK says.

clock 03 May 2011 •

Long Term Care

Man awarded £27K after PCT botched father's care assessment

A man has been awarded £27,000 after his local primary care trust (PCT) wrongly assessed his father's long term care (LTC) needs.

clock 03 May 2011 •

Protection

IFAs will focus on protection post RDR - Aviva

Over half (57%) of IFAs will target protection sales as a source of new revenue post Retail Distribution Review (RDR), Aviva has found.

clock 28 April 2011 •
204205206
  • Contact Us
  • Marketing Solutions
  • About Incisive Media
  • Privacy Settings
  • Careers
  • Terms & Conditions
  • Policies
FOLLOW US
Incisive Media

© Incisive Business Media Limited, Published by Incisive Business Media Limited, New London House, 172 Drury Lane, London WC2B 5QR. Registered in England and Wales with company registration number 09178013. Part of Arc network, www.arc-network.com

DIGITAL PUBLISHER OF THE YEAR
right wallpaper ad
Loading.gif?category=protection&page type=listing page